Sudarshan Pharma Shares Rise After NSE Listing Ahead of Board Meeting on Fundraising
Shares of Sudarshan Pharma Industries rose between 7% and 9% following its migration from the BSE SME platform to the NSE main board on October 27, 2026. The company’s board is set to meet on October 29 to review Q2 FY27 financial results and consider a fundraising proposal. Sudarshan Pharma has shown strong stock performance over recent months and is also pursuing an acquisition of a US-based biotech firm, pending due diligence and approvals.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (68/100). Lens Score 41/100.
Outlets measured: mint, indiatvnews. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (65–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
indiatvnews broke this story on 28 Oct, 10:55 am. Other outlets followed.